Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Metabolic & Longevity/ AOD-9604
In stock
AOD-9604

AOD-9604

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide fragment corresponding to the C-terminal region (Tyr-hGH177–191) of human growth hormone, modified with a tyrosine residue at the N-terminus to enhance stability; CAS 221231-10-3; molecular formula C78H123N23O23S2; molecular weight 1815.1 g/mol; studied in adipogenesis, lipolysis regulation, and metabolic research models. Supplied lyophilised at HPLC ≥99% purity. For laboratory research use only; not for human or veterinary use.

Derived from the very tail of the human growth-hormone molecule, AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of hGH (residues 177-191) with an added tyrosine and a stabilising disulfide bridge. It was designed around a simple hypothesis: that the fat-metabolising activity of growth hormone could be isolated from the rest of its signalling, and it has since become a reference compound in metabolic-peptide research.

One function, distilled from a larger hormone. Full-length growth hormone exerts many effects, of which lipid mobilisation is only one. Investigators mapped this lipolytic activity to the hormone's C-terminal region and synthesised the corresponding fragment to probe it in isolation (Ng et al., 2000). Because the peptide reproduces fat-metabolism signalling without acting through the classic IGF-1-raising pathway, it offered a cleaner experimental window into adipocyte regulation.

What the research explores. The fragment has been examined across metabolic and musculoskeletal models:

  • Lipid metabolism — characterised for its effects on lipolysis and lipogenesis in fat tissue and animal models (Heffernan et al., 2001; Ng et al., 2000).
  • Metabolic-disease context — reviewed as an investigational metabolic agent (Wilding et al., 2004).
  • Cartilage & joint models — studied via intra-articular injection, with and without hyaluronic acid, in a rabbit osteoarthritis model (Kwon et al., 2015).
  • In vitro metabolism & detection — its metabolic fate and analytical detection have been characterised (Cox et al., 2015).

All such findings stem from in vitro and animal research; no human-use conclusions are implied. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS 221231-10-3 · Molecular formula C₇₈H₁₂₃N₂₃O₂₃S₂ · Molecular weight 1815.1 · Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Cys⁷–Cys¹⁴ disulfide) · Appearance: white lyophilized powder · Solubility: soluble in water.

Specification & quality. Each individually sealed vial contains 5 mg of AOD-9604 as a white lyophilized powder of ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture. Shelf life: 24 months from the manufacture date.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number221231-10-3
Molecular formulaC₇₈H₁₂₃N₂₃O₂₃S₂
Molecular weight1815.1
SequenceTyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Cys⁷–Cys¹⁴ disulfide)
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity5mg/vial
SolubilitySoluble in water
StorageStore at -20°C, protect from light
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Wilding J. AOD-9604 Metabolic. Curr Opin Investig Drugs. 2004;5(4):436-40. PMID: 15134286. PubMed 02 Kwon DR, Park GY. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Ann Clin Lab Sci. 2015;45(4):426-32. PMID: 26275694. PubMed 03 Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015;7(1):31-8. PMID: 25208511. doi:10.1002/dta.1715. PubMed 04 Vanhee C, Moens G, Deconinck E, De Beer JO. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604. Drug Test Anal. 2014;6(9):964-8. PMID: 24976118. doi:10.1002/dta.1687. PubMed 05 Orlovius AK, Thomas A, Schänzer W, Thevis M. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug Test Anal. 2013;5(11-12):850-2. PMID: 24124033. doi:10.1002/dta.1557. PubMed 06 Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001;142(12):5182-9. PMID: 11713213. doi:10.1210/endo.142.12.8522. PubMed 07 Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-8. PMID: 11146367. doi:10.1159/000053183. PubMed 08 Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. PMID: 41966639. doi:10.1007/s40279-026-02437-0. PubMed 09 Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. 2026;10(1). PMID: 41490200. doi:10.5435/JAAOSGlobal-D-25-00236. PubMed 10 Thevis M, Schänzer W. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. J Pharm Biomed Anal. 2014;101:66-83. PMID: 24906629. doi:10.1016/j.jpba.2014.05.020. PubMed 11 Khan A, Raza S, Khan Y, Aksoy T, Khan M, Weinberger Y, et al. Current updates in the medical management of obesity. Recent Pat Endocr Metab Immune Drug Discov. 2012;6(2):117-28. PMID: 22435392. doi:10.2174/187221412800604644. PubMed 12 Zieba R. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development]. Postepy Hig Med Dosw (Online). 2007;61:612-26. PMID: 17971763. PubMed 13 Jensen MD. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors. Obesity (Silver Spring). 2006;14 Suppl 3:143S-149S. PMID: 16931496. doi:10.1038/oby.2006.294. PubMed 14 Halford JC. Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006;7(4):312-8. PMID: 16625817. PubMed 15 Thomas A, Görgens C, Guddat S, Thieme D, Dellanna F, Schänzer W, et al. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. J Sep Sci. 2016;39(2):333-41. PMID: 26578461. doi:10.1002/jssc.201501060. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of human growth hormone (residues 177-191), with an added tyrosine and a stabilizing disulfide bridge. Unlike a secretagogue, it derives from the GH molecule itself. Condor Research supplies it as a 5 mg vial, ≥99% HPLC, strictly for in-vitro research use.

AOD-9604 reproduces only the C-terminal fragment (residues 177-191) of growth hormone that is associated with its lipolytic activity, rather than the signaling apparatus that triggers GH release. So it is a GH-derived fragment, not a secretagogue: it does not stimulate the GHRH or ghrelin receptors the way CJC-1295 or Ipamorelin do. It is a Research Use Only reference peptide.

They sit at different points of the GH axis. CJC-1295 is a GHRH-analogue secretagogue, modeled on the hormone that signals upstream to release growth hormone. AOD-9604 is instead a fragment of the GH molecule itself (residues 177-191), studied for the lipolytic domain. Both are supplied strictly as in-vitro research materials.

Tesamorelin is a GHRH analogue, a secretagogue-type molecule acting upstream of growth hormone. AOD-9604 is a fragment of the GH molecule itself (residues 177-191), studied as its lipolytic domain rather than as a release-stimulating signal. They are distinct research peptides addressing opposite ends of GH biology, both sold for in-vitro use only.

They represent different layers of the GH/IGF axis. AOD-9604 is a short fragment of growth hormone itself (residues 177-191). IGF-1 LR3 is a much larger 83-residue recombinant analogue of insulin-like growth factor-1, the downstream effector. So AOD-9604 sits at the GH level and IGF-1 LR3 at the IGF level. Both are Research Use Only reference materials.

AOD-9604 is a peptide fragment of growth hormone (residues 177-191), water-soluble and supplied as a lyophilate. SLU-PP-332 is a non-peptide small-molecule ERR agonist, soluble in DMSO. They are entirely different compound classes studied in metabolic research. Both are offered strictly as in-vitro reference materials, with no use protocols provided.

Each lot is tested by an independent third-party laboratory, with identity and purity confirmed by HPLC and mass spec, and ships with a batch-specific Certificate of Analysis certifying ≥99% purity. The listed sequence, disulfide bridge and molecular weight (1815.1) correspond to AOD-9604. To request the current lot COA, email info@condorresearch.com.

AOD-9604 is a water-soluble lyophilized powder, dissolved in a compatible aqueous diluent for in-vitro preparation, with volume chosen to reach the target analytical concentration from the 5 mg vial. Store the sealed vial at -20°C, protected from light (24-month shelf life). This is analytical preparation only; no human or veterinary dosing guidance is provided.

No — AOD-9604 is supplied strictly as a Research Use Only (in vitro) reference material: not a medicine, supplement or medical device, and not for human or veterinary administration or consumption. Sales are restricted to professionals and institutions aged 18+. Buyers are responsible for confirming the legality of import in their own jurisdiction.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.6
30 verified reviews
5
77%
4
17%
3
3%
2
0%
1
3%
Apr 2026
Reference-grade consistency

Reconstitution was clean with no visible particulates. The lot-specific COA matched the assay we ran in-house — purity is exactly as stated.

Dr. M. Hartmann · Research lab · DE Verified purchase
Mar 2026
COA matched our own HPLC

We verify every incoming compound by HPLC; this batch came back within tolerance of the certificate. Dispatch from the EU warehouse was quick.

L. Fischer · University group · AT Verified purchase
Mar 2026
Impeccable packaging

Cold-chain handling was respected end to end. Vials arrived sealed, labelled and intact. Documentation is the most thorough I've seen from an EU supplier.

Dr. S. Novak · Private lab · CZ Verified purchase
Feb 2026
Reliable, well documented

Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.

P. Andersson · Research institute · SE Verified purchase

Related compounds